A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5.
A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5.
复制标题
DOI:
10.4049/jimmunol.179.7.4849
复制
发表时间:
2007-10-01
期刊:
影响因子:
--
通讯作者:
Ahluwalia A
中科院分区:
文献类型:
--
作者:
Duchene J;Lecomte F;Ahmed S;Cayla C;Pesquero J;Bader M;Perretti M;Ahluwalia A
The kinin B1 receptor is an inducible receptor not normally expressed but induced by inflammatory stimuli and plays a major role in neutrophil recruitment, particularly in response to the cytokine interleukin-1β (IL-1β). However, the exact mechanism involved in this response is unclear. The aim of this study was to dissect the molecular mechanism involved, in particular to determine whether specific ELR-CXCL chemokines (specific neutrophil chemoattractants) played a role. Using intravital microscopy, we demonstrated that IL-1 β induced leukocyte rolling, adherence and emigration in mesenteric venules of wild type (WT) mice, associated with an increase of B1 receptor mRNA expression, was substantially attenuated (>80%) in B1 receptor knockout mice (B1KO). This effect in B1KO mice was correlated with a selective down regulation of IL-1β-induced CXCL5 mRNA and protein expression compared to WT mice. Furthermore a selective neutralizing CXCL5 antibody caused profound suppression of leukocyte emigration in IL-1β treated WT mice. Finally, treatment of human endothelial cells with IL-1β enhanced mRNA expression of B1 receptor and the human CXCL5 homologues (hCXCL5 and hCXCL6). This response was suppressed by ~50% when cells were pretreated with the B1 receptor antagonist des-Arg9[Leu]8BK whilst treatment with des-Arg9-BK, the B1 receptor agonist, caused a concentration-dependent increase in hCXCL5 and hCXCL6 mRNA expression. This study unveils a pro-inflammatory pathway centred on kinin B1 receptor activation of CXCL5 leading to leukocyte trafficking, and highlights the B1 receptor as a potential target in the therapeutics of inflammatory disease.
登录
查看更多内容
影响因子:
5.3
作者:
Ferreira, J;Beirith, A;Calixto, JB
通讯作者:
Calixto, JB
影响因子:
6.5
作者:
Goebeler, M;Yoshimura, T;Gillitzer, R
通讯作者:
Gillitzer, R
影响因子:
3.2
作者:
McIntyre, TM;Prescott, SM;Zimmerman, GA
通讯作者:
Zimmerman, GA
影响因子:
5.5
作者:
Ehrenfeld, P.;Millan, C.;Figueroa, C. D.
通讯作者:
Figueroa, C. D.
影响因子:
20.1
作者:
Madorin, WS;Rui, T;Kvietys, PR
通讯作者:
Kvietys, PR